United States Small Molecule Active Pharmaceutical Ingredient Market Report 2017

Name: United States Small Molecule Active Pharmaceutical Ingredient Market Report 2017
Brand: QYResearch
SKU: U1B17D3C0F7EN
Price: 3800 USD
Availability: InStock

August 2017 | 117 pages | ID: U1B17D3C0F7EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Small Molecule Active Pharmaceutical Ingredient market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Small Molecule Active Pharmaceutical Ingredient in these regions, from 2012 to 2022 (forecast).

United States Small Molecule Active Pharmaceutical Ingredient market competition by top manufacturers/players, with Small Molecule Active Pharmaceutical Ingredient sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Johnson Matthey
Siegfried Holding AG
Pfizer
Sanofi S.A.
Novartis AG,
Bristol-Myers Squibb
Boehringer Ingelheim GmbH
GlaxoSmithKline
Albany Molecular Research Inc.
Bachem Holding AG
PCAS
Patheon N.V.
AstraZeneca
Johnson & Johnson
Merck & Co, Inc.
BASF SE
Catalent Inc.
Teva Pharmaceuticals
Roche
Cambrex Corporation?
GILEAD Science Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Standard API
High Potency API

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Small Molecule Active Pharmaceutical Ingredient for each application, including

Cardiovascular Diseases
Respiratory Disorders
Infectious Diseases
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Small Molecule Active Pharmaceutical Ingredient Market Report 2017

1 SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT OVERVIEW

1.1 Product Overview and Scope of Small Molecule Active Pharmaceutical Ingredient
1.2 Classification of Small Molecule Active Pharmaceutical Ingredient by Product Category
  1.2.1 United States Small Molecule Active Pharmaceutical Ingredient Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Small Molecule Active Pharmaceutical Ingredient Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Standard API
  1.2.4 High Potency API
1.3 United States Small Molecule Active Pharmaceutical Ingredient Market by Application/End Users
  1.3.1 United States Small Molecule Active Pharmaceutical Ingredient Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cardiovascular Diseases
  1.3.3 Respiratory Disorders
  1.3.4 Infectious Diseases
  1.3.5 Others
1.4 United States Small Molecule Active Pharmaceutical Ingredient Market by Region
  1.4.1 United States Small Molecule Active Pharmaceutical Ingredient Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Small Molecule Active Pharmaceutical Ingredient Status and Prospect (2012-2022)
  1.4.3 Southwest Small Molecule Active Pharmaceutical Ingredient Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Small Molecule Active Pharmaceutical Ingredient Status and Prospect (2012-2022)
  1.4.5 New England Small Molecule Active Pharmaceutical Ingredient Status and Prospect (2012-2022)
  1.4.6 The South Small Molecule Active Pharmaceutical Ingredient Status and Prospect (2012-2022)
  1.4.7 The Midwest Small Molecule Active Pharmaceutical Ingredient Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Small Molecule Active Pharmaceutical Ingredient (2012-2022)
  1.5.1 United States Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2022)
  1.5.2 United States Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2022)

2 UNITED STATES SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Small Molecule Active Pharmaceutical Ingredient Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Small Molecule Active Pharmaceutical Ingredient Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Small Molecule Active Pharmaceutical Ingredient Average Price by Players/Suppliers (2012-2017)
2.4 United States Small Molecule Active Pharmaceutical Ingredient Market Competitive Situation and Trends
  2.4.1 United States Small Molecule Active Pharmaceutical Ingredient Market Concentration Rate
  2.4.2 United States Small Molecule Active Pharmaceutical Ingredient Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Region (2012-2017)
3.2 United States Small Molecule Active Pharmaceutical Ingredient Revenue and Market Share by Region (2012-2017)
3.3 United States Small Molecule Active Pharmaceutical Ingredient Price by Region (2012-2017)

4 UNITED STATES SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Small Molecule Active Pharmaceutical Ingredient Revenue and Market Share by Type (2012-2017)
4.3 United States Small Molecule Active Pharmaceutical Ingredient Price by Type (2012-2017)
4.4 United States Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Application (2012-2017)
5.2 United States Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Johnson Matthey
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Siegfried Holding AG
  6.2.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi S.A.
  6.4.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Novartis AG,
  6.5.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bristol-Myers Squibb
  6.6.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Boehringer Ingelheim GmbH
  6.7.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
  6.8.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Albany Molecular Research Inc.
  6.9.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Bachem Holding AG
  6.10.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 PCAS
6.12 Patheon N.V.
6.13 AstraZeneca
6.14 Johnson & Johnson
6.15 Merck & Co, Inc.
6.16 BASF SE
6.17 Catalent Inc.
6.18 Teva Pharmaceuticals
6.19 Roche
6.20 Cambrex Corporation?
6.21 GILEAD Science Inc.

7 SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURING COST ANALYSIS

7.1 Small Molecule Active Pharmaceutical Ingredient Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Small Molecule Active Pharmaceutical Ingredient Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Small Molecule Active Pharmaceutical Ingredient Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Small Molecule Active Pharmaceutical Ingredient Sales Volume Forecast by Type (2017-2022)
11.3 United States Small Molecule Active Pharmaceutical Ingredient Sales Volume Forecast by Application (2017-2022)
11.4 United States Small Molecule Active Pharmaceutical Ingredient Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Small Molecule Active Pharmaceutical Ingredient
Figure United States Small Molecule Active Pharmaceutical Ingredient Market Size (K MT) by Type (2012-2022)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Volume Market Share by Type (Product Category) in 2016
Figure Standard API Product Picture
Figure High Potency API Product Picture
Figure United States Small Molecule Active Pharmaceutical Ingredient Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Small Molecule Active Pharmaceutical Ingredient by Application in 2016
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Respiratory Disorders Examples
Table Key Downstream Customer in Respiratory Disorders
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Small Molecule Active Pharmaceutical Ingredient Market Size (Million USD) by Region (2012-2022)
Figure The West Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2022)
Figure United States Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Small Molecule Active Pharmaceutical Ingredient Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Small Molecule Active Pharmaceutical Ingredient Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Small Molecule Active Pharmaceutical Ingredient Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Small Molecule Active Pharmaceutical Ingredient Sales Share by Players/Suppliers
Figure 2017 United States Small Molecule Active Pharmaceutical Ingredient Sales Share by Players/Suppliers
Figure United States Small Molecule Active Pharmaceutical Ingredient Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Small Molecule Active Pharmaceutical Ingredient Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Small Molecule Active Pharmaceutical Ingredient Revenue Share by Players/Suppliers
Figure 2017 United States Small Molecule Active Pharmaceutical Ingredient Revenue Share by Players/Suppliers
Table United States Market Small Molecule Active Pharmaceutical Ingredient Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Small Molecule Active Pharmaceutical Ingredient Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Small Molecule Active Pharmaceutical Ingredient Market Share of Top 3 Players/Suppliers
Figure United States Small Molecule Active Pharmaceutical Ingredient Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Small Molecule Active Pharmaceutical Ingredient Product Category
Table United States Small Molecule Active Pharmaceutical Ingredient Sales (K MT) by Region (2012-2017)
Table United States Small Molecule Active Pharmaceutical Ingredient Sales Share by Region (2012-2017)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Share by Region (2012-2017)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region in 2016
Table United States Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Small Molecule Active Pharmaceutical Ingredient Revenue Share by Region (2012-2017)
Figure United States Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region (2012-2017)
Figure United States Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region in 2016
Table United States Small Molecule Active Pharmaceutical Ingredient Price (USD/MT) by Region (2012-2017)
Table United States Small Molecule Active Pharmaceutical Ingredient Sales (K MT) by Type (2012-2017)
Table United States Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2012-2017)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2012-2017)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2016
Table United States Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Small Molecule Active Pharmaceutical Ingredient Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Small Molecule Active Pharmaceutical Ingredient by Type (2012-2017)
Figure Revenue Market Share of Small Molecule Active Pharmaceutical Ingredient by Type in 2016
Table United States Small Molecule Active Pharmaceutical Ingredient Price (USD/MT) by Types (2012-2017)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate by Type (2012-2017)
Table United States Small Molecule Active Pharmaceutical Ingredient Sales (K MT) by Application (2012-2017)
Table United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2012-2017)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2012-2017)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2016
Table United States Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate by Application (2012-2017)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate by Application (2012-2017)
Table Johnson Matthey Basic Information List
Table Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2012-2017)
Figure Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales Market Share in United States (2012-2017)
Figure Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in United States (2012-2017)
Table Siegfried Holding AG Basic Information List
Table Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2012-2017)
Figure Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Market Share in United States (2012-2017)
Figure Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2012-2017)
Figure Pfizer Small Molecule Active Pharmaceutical Ingredient Sales Market Share in United States (2012-2017)
Figure Pfizer Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in United States (2012-2017)
Table Sanofi S.A. Basic Information List
Table Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2012-2017)
Figure Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales Market Share in United States (2012-2017)
Figure Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in United States (2012-2017)
Table Novartis AG, Basic Information List
Table Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2012-2017)
Figure Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales Market Share in United States (2012-2017)
Figure Novartis AG, Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in United States (2012-2017)
Table Albany Molecular Research Inc. Basic Information List
Table Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2012-2017)
Figure Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales Market Share in United States (2012-2017)
Figure Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in United States (2012-2017)
Table Bachem Holding AG Basic Information List
Table Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2012-2017)
Figure Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Market Share in United States (2012-2017)
Figure Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in United States (2012-2017)
Table PCAS Basic Information List
Table Patheon N.V. Basic Information List
Table AstraZeneca Basic Information List
Table Johnson & Johnson Basic Information List
Table Merck & Co, Inc. Basic Information List
Table BASF SE Basic Information List
Table Catalent Inc. Basic Information List
Table Teva Pharmaceuticals Basic Information List
Table Roche Basic Information List
Table Cambrex Corporation? Basic Information List
Table GILEAD Science Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Small Molecule Active Pharmaceutical Ingredient
Figure Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient
Figure Small Molecule Active Pharmaceutical Ingredient Industrial Chain Analysis
Table Raw Materials Sources of Small Molecule Active Pharmaceutical Ingredient Major Players/Suppliers in 2016
Table Major Buyers of Small Molecule Active Pharmaceutical Ingredient
Table Distributors/Traders List
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Small Molecule Active Pharmaceutical Ingredient Price (USD/MT) Trend Forecast (2017-2022)
Table United States Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Type in 2022
Table United States Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Application in 2022
Table United States Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Small Molecule Active Pharmaceutical Ingredient Sales Volume Share Forecast by Region (2017-2022)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Volume Share Forecast by Region (2017-2022)
Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Small Molecule Active Pharmaceutical Ingredient Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports